- Title: Subtitle
- From the ASPREE investigators: Response to Wittes et al
- Creators
- John J McNeilAndrew M TonkinAnne B NewmanJeff D WilliamsonRobyn L WoodsAndrew T ChanGeoffrey A DonnanChristopher M ReidMark R NelsonSara E EspinozaWalter P AbhayaratnaRaj C ShahPeter GibbsMichael E ErnstNigel P StocksLawrence J BeilinBrenda KirpachJoanne RyanRory WolfeAnne M MurrayKaren L Margolis
- Resource Type
- Letter/Communication
- Publication Details
- Clinical trials (London, England)
- DOI
- 10.1177/17407745251344560
- PMID
- 40618233
- PMCID
- PMC12318158
- NLM abbreviation
- Clin Trials
- ISSN
- 1740-7753
- eISSN
- 1740-7753
- Publisher
- SAGE PUBLICATIONS LTD
- Grant note
- National Institute on Aging at the National Institutes of Health: U01AG029824, U19AG062682 National Cancer Institute at the National Institutes of Health: U01AG029824, U19AG062682 National Health and Medical Research Council of Australia: 334047, 1127060 Monash UniversityVictorian Cancer Agency
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: ASPREE was funded by the National Institute on Aging and the National Cancer Institute at the National Institutes of Health (grant numbers U01AG029824 and U19AG062682); the National Health and Medical Research Council of Australia (grant numbers 334047 and 1127060); Monash University; and the Victorian Cancer Agency.
- Language
- English
- Date published
- 07/06/2025
- Academic Unit
- Family and Community Medicine; Pharmacy Practice and Science
- Record Identifier
- 9984843747302771
Letter/Communication
From the ASPREE investigators: Response to Wittes et al
Clinical trials (London, England)
07/06/2025
DOI: 10.1177/17407745251344560
PMCID: PMC12318158
PMID: 40618233
Details
Metrics
1 Record Views